Last updated on April 2019

Determining the Prognostic Value of Continuous Intrathecal Infusion


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Vertebral Compression Fracture | Failed Back Surgery Syndrome | Chronic Low Back Pain | Lumbar Post-Laminectomy Syndrome
  • Age: Between 30 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Previous lumbar or thoracic spine surgery or lower thoracic/lumbar vertebral compression fracture
  • Intractable pain of trunk (more than limbs)
  • Patient who passed psychological evaluations as part of the usual clinical care prior to consideration of IDDS and are stable with current pain condition and medications
  • Failed more conservative management.

Exclusion Criteria:

  • Untreated coagulopathy or infection.
  • Immune compromised state precluding having an implant.
  • Allergic reactions to bupivacaine or fentanyl.
  • Pregnancy
  • Patients using more than 30 mg oral equivalents of morphine daily or who are unable to wean down below that dosage for more than 4 weeks before the prognostic intrathecal infusion test.
  • Neurological deficits characterized as weakness in lower extremities with evidence of nerve damage
  • Patients with cognitive disorders who would not be able to provide meaningful outcome responses

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.